DOI: 10.1055/s-00000161

The Journal of Knee Surgery

References

Delforge M, Terpos E, Richardson PG. , et al.
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.

Eur J Haematol 2011;
86 (05) 372-384

Download Bibliographical Data

Access:
Access: